4-81045947-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001201.5(BMP3):c.526C>A(p.Gln176Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,613,990 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q176L) has been classified as Likely benign.
Frequency
Consequence
NM_001201.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00846 AC: 1287AN: 152130Hom.: 24 Cov.: 33
GnomAD3 exomes AF: 0.00207 AC: 519AN: 250972Hom.: 2 AF XY: 0.00161 AC XY: 219AN XY: 135636
GnomAD4 exome AF: 0.000927 AC: 1355AN: 1461742Hom.: 14 Cov.: 30 AF XY: 0.000802 AC XY: 583AN XY: 727174
GnomAD4 genome AF: 0.00846 AC: 1288AN: 152248Hom.: 24 Cov.: 33 AF XY: 0.00873 AC XY: 650AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 15, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at